Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 365 publications
Efficacy and Safety of Tildrakizumab in Elderly Patients With Psoriasis: A Narrative Review.
Journal: The Journal of clinical and aesthetic dermatology
Published: July 16, 2026
Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2025 Annual Meeting.
Journal: The Journal of rheumatology
Published: July 07, 2026
Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double-Blind, Phase 3 POETYK PsA-2 Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: May 12, 2026
The efficacy and safety of interleukin-17 and interleukin-23 inhibitors in psoriatic arthritis across multiple disease domains.
Journal: Dermatology online journal
Published: April 07, 2026
A review of the indications, safety, and efficacy of deucravacitinib: An expert consensus panel.
Journal: Dermatology online journal
Published: March 24, 2026
Three-Year Patient-Reported Outcomes From Bimekizumab for Plaque Psoriasis: The BE RADIANT Randomized Clinical Trial With Open-Label Extension.
Journal: JAMA dermatology
Published: February 18, 2026
Association Between Bimekizumab's Clinical Response and Patient-Reported Benefits on Health-Related Quality of Life: Results from BE HEARD I and II.
Journal: Dermatology and therapy
Published: February 15, 2026
Hidradenitis Suppurativa Patients Experience a Significant Musculoskeletal Symptom Burden: A Quality Improvement Initiative Using the IDEOM MSK-Q.
Journal: The Journal of clinical and aesthetic dermatology
Published: December 19, 2025
Report From the 2024 International Dermatology Outcome Measures (IDEOM) Annual Meeting.
Journal: Journal of drugs in dermatology : JDD
Published: December 02, 2025
Understanding the Resolution of Clinically Suspect Arthralgia: Moving Forward, but Challenges Remain.
Journal: The Journal of rheumatology
Published: December 01, 2025
Real-World Burden of Generalized Pustular Psoriasis in a French Observational Study: Prevalence, Incidence, Healthcare Resource Utilization, Comorbidities, Treatment Use, and Mortality.
Journal: Dermatology and therapy
Published: November 27, 2025
Refractory Pruritus Secondary to Linear IgA Bullous Dermatosis Treated Successfully With Nemolizumab: A Case Report.
Journal: Journal of drugs in dermatology : JDD
Published: October 02, 2025
Last Updated: 09/26/2026